NTX Blood Bank Cost Per Test

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

257-NETWORK CONTRACT OFFICE 17 (36C257)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C25726Q0870

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

NONE

Place of Performance

Texas, UNITED STATES

SourceSAM
The "NTX Blood Bank Cost Per Test" procurement, identified under solicitation number 36C25726Q0870, represents an awarded contract initiated by the Department of Veterans Affairs, specifically through the 257-Network Contract Office 17. The primary objective of this procurement is to secure in-vitro diagnostic substances and related services for blood bank testing, with a focus on cost-per-test arrangements. This approach is designed to ensure efficient, reliable, and cost-effective diagnostic testing capabilities for the VA’s healthcare facilities within Texas. The scope of this contract encompasses the provision of diagnostic substances used in blood bank operations, aligning with NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) and Product Service Code 6550. The intended outcome is to support the VA’s mission of delivering high-quality healthcare services to veterans by maintaining robust and compliant blood testing protocols. Contractors are expected to supply products that meet stringent regulatory standards and are suitable for clinical use in a hospital or laboratory setting. This procurement is not subject to any set-aside restrictions, indicating that it was open to all qualified vendors without limitations based on business size or socioeconomic status. The place of performance is specified as Texas, United States, reflecting the regional focus of the contract and the VA’s commitment to serving veterans within this geographic area. The contracting activity is managed by the 257-Network Contract Office 17, a federal office under the Department of Veterans Affairs. The primary point of contact for this procurement is Teresa Arzola, who can be reached via email at [email protected] or by phone at 210.740.3729. Interested parties and stakeholders can access further details and monitor the status of this award through the official SAM.gov opportunity listing at https://sam.gov/opp/826e0448015647979cae380ae2c4a67b/view. Overall, this contract is structured to provide ongoing, reliable access to essential blood bank diagnostic substances, supporting the VA’s operational needs and ensuring continuity of care for veterans in Texas. Contractors evaluating this opportunity should note the federal contracting environment, the absence of set-aside requirements, and the expectation for high-quality, compliant deliverables that align with the VA’s healthcare standards.